Host: | Mouse |
Applications: | IHC-P |
Reactivity: | Human |
Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description : | Mouse monoclonal antibody anti-Wilms Tumor is suitable for use in Immunohistochemistry research applications. |
Clonality : | Monoclonal |
Clone ID : | WT49 |
Conjugation: | Unconjugated |
Isotype: | IgG1 |
Formulation: | Tissue culture supernatant with sodium azide |
Concentration: | >=44 mg/L |
Dilution Range: | IHC-P 1:100 |
Storage Instruction: | Store at 2-8°C upon receipt. |
Immunogen: | A prokaryotic recombinant protein containing 1–181 amino acids of the N-terminal of the Wilms Tumor protein. |
Background | Wilms tumor protein (WT1) has a role in transcriptional regulation and is expressed in the kidney and a subset of hematopoietic cells. Alteration of transcription factor function is a common mechanism in oncogenesis. The WT1 protein contains a DNA binding domain and any deletions or point mutations of the WT1 gene which destroy this activity result in the development of the childhood nephroblastoma Wilms tumor and Denys-Drash syndrome. The description of WT1 involvement in nephroblastoma is not clear. |
Information sourced from Uniprot.org